- 80%accuracy in NLP classification
WHO ARE THEY?
GlaxoSmithKline (GSK) is a global healthcare company based in London. It is one of the largest pharmaceutical companies in the world. When developing new products, part of the process includes the rigorous testing of these products through drug trials. GSK tasked Peak with improving its processes for classifying the open text field data receieved as part of drug trials.
WHAT WAS THE CHALLENGE?
When GSK run drug trials, they have MSLs (Medical Science Liaisons) whom they connect with in order to obtain various information from healthcare professionals. The MSLs conduct interviews with these professionals, and input the information as raw, unstructured text data, and then send it to GSK. Issues arise when GSK has to manually label and classify this information; it’s extremely time-consuming and different GSK employees may subjectively classify responses in different ways.
WHAT DID PEAK DO?
Peak has developed a unique Natural Language Processing (NLP) classification model for GSK, powered by the Peak AI System. This model is used to label a controlled set of sentences. Ambiguity is high in open field text, so to handle this, Peak’s model can provide up to two or three labels (if appropriate) to any given comment.
This increases the value and accuracy of a particular comment compared to only using one label. The model can also run through all historic responses, as well as ones that will be input in the future, in order to standardise all labels and remove any subjectiveness.
NATURAL LANGUAGE PROCESSING
Natural language processing, or NLP, is the application of computational techniques to the analysis and synthesis of natural language and speech.
WHAT’S THE UPSHOT?
The model provides GSK with a more efficient way of labelling sentences than their previous manual methods. GSK ran strict testing of Peak’s model on a controlled data set, which delivered results with 80% accuracy. One of the other main benefits of the Peak model was the ability to assign more than one label to particular sentences. 70% of all sentences were assigned a second label, with 30% assigned a third label – allowing GSK to perform more in-depth analysis of this important language data.
“We’ve achieved some fantastic results for GSK through the development of a unique Natural Language Processing classification model. With 80% accuracy, our model is enabling GSK to make better, smarter use of the language data they receive, saving their team a significant amount of time in the process.” Richard Potter, CEO, Peak
This customer story provides an insight into how Peak can help businesses to grow. To learn more about how we can help you with increasing sales and company performance using predictive analytics and machine learning, have a chat to one of our directors. We’ll tell what’s possible, with no hard sell.